ganetespib
Showing 1 - 25 of 33
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Worldwide (Ganetespib, Niraparib, Carboplatin)
Unknown status
- Ovarian Cancer
- +2 more
- Ganetespib
- +4 more
-
Innsbruck, Austria
- +12 more
Jan 26, 2021
Advanced Lung Cancer Trial in United States (Ganetespib (STA-9090) and crizotinib)
Completed
- Advanced Lung Cancer
- Ganetespib (STA-9090) and crizotinib
-
Basking Ridge, New Jersey
- +4 more
Dec 28, 2020
Lung Cancer - Malignant Pleural Mesothelioma Trial in London (Ganetespib)
Completed
- Lung Cancer - Malignant Pleural Mesothelioma
- Ganetespib
-
London, United KingdomUCL Cancer Trials Centre
Nov 8, 2019
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus
Completed
- Gastroesophageal Junction Adenocarcinoma
- +7 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2019
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (Ganetespib, Paclitaxel)
Terminated
- Epithelial Ovarian Cancer
- +2 more
- Ganetespib
- Paclitaxel
-
Innsbruck, Austria
- +9 more
Jun 25, 2019
Malignant Peripheral Nerve Sheath Tumors (MPNST), Sarcoma Trial in United States (ganetespib, Sirolimus)
Completed
- Malignant Peripheral Nerve Sheath Tumors (MPNST)
- Sarcoma
- ganetespib
- Sirolimus
-
Santa Monica, California
- +6 more
May 1, 2019
Breast Cancer Trial in Boston, Concord, Chapel Hill (Fulvestrant, Ganetespib)
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in New York (ganetespib, paclitaxel, trastuzumab)
Completed
- HER2-positive Breast Cancer
- +6 more
- ganetespib
- +3 more
-
New York, New York
- +1 more
Jun 13, 2018
Cancer, Small Cell Lung Cancer Trial in Washington (Ganetespib, Doxorubicin)
Terminated
- Cancer
- Small Cell Lung Cancer
- Ganetespib
- Doxorubicin
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Mar 22, 2018
Tumors Trial run by the NCI (Ziv-Aflibercept, Ganetespib)
Terminated
- Neoplasms
- Ziv-Aflibercept
- Ganetespib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2018
Melanoma Trial in Boston (STA-9090)
Terminated
- Melanoma
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 1, 2017
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- Hsp90 inhibitor STA-9090
- +7 more
-
Baltimore, Maryland
- +3 more
Aug 19, 2018
Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma, Stage I Oral Cavity Squamous Cell
Terminated
- Stage I Hypopharyngeal Squamous Cell Carcinoma
- +15 more
- Ganetespib
- +2 more
-
Atlanta, Georgia
- +1 more
Jul 22, 2016
Breast Cancer Trial (Ganetespib, Paclitaxel, Doxorubicin)
Withdrawn
- Breast Cancer
- Ganetespib
- +3 more
- (no location specified)
May 26, 2016
Rectal Cancer Trial in Atlanta (capecitabine + ganetespib)
Completed
- Rectal Cancer
- capecitabine + ganetespib
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Feb 19, 2016
Gastrointestinal Stromal Tumor Trial in United States (Ganetespib)
Completed
- Gastrointestinal Stromal Tumor
- Ganetespib
-
Los Angeles, California
- +3 more
Feb 11, 2016
Multiple Myeloma Trial in United States (Ganetespib, Bortezomib, Dexamethasone)
Completed
- Multiple Myeloma
- Ganetespib
- +2 more
-
Denver, Colorado
- +7 more
Oct 8, 2015
Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (ganetespib)
Completed
- Breast Cancer
- +3 more
- ganetespib
-
Birmingham, Alabama
- +24 more
Nov 4, 2015
Non-Small-Cell Lung Adenocarcinoma, NSCLC Stage IIIB, NSCLC Stage IV Trial in Worldwide (Docetaxel, Ganetespib)
Terminated
- Non-Small-Cell Lung Adenocarcinoma
- +3 more
- Docetaxel
- Ganetespib
-
Flagstaff, Arizona
- +267 more
May 26, 2016
NSCLC Stage IIIB, NSCLC Stage IV, NSCLC Metastatic Trial in Worldwide (Docetaxel, Combination of ganetespib and docetaxel)
Terminated
- Non-small Cell Lung Cancer Stage IIIB
- +2 more
- Docetaxel
- Combination of ganetespib and docetaxel
-
Tucson, Arizona
- +52 more
Nov 4, 2015